Tool Create startup animated videos in minutes, not in hours! 

 4 days ago

Omega Therapeutics Lands $85M in Financing

Quick Summary

Omega Therapeutics Lands $85M in Financing Back to HomeCAMBRIDGE, MA, Omega Therapeutics announced the completion of an $85 million financing. Omega Therapeutics™, a company pioneering a new category of genomic medicine through epigenomic programming, today announced the completion of an $85 million financing. Coordinated changes in epigenomic programming drive the cellular variation that controls human biology, in both healthy and diseased states. "We are advancing the frontiers of medicine through epigenomic programming," said Mahesh Karande, President and Chief Executive Officer of Omega Therapeutics. About Omega TherapeuticsOmega Therapeutics is a genomic medicine company advancing novel engineered therapeutics, Omega's Epigenomic Controllers, enabling controllable epigenomic programming into clinical development for a broad range of indications.

Disclaimer: This story is auto-aggregated & summarized by a computer program and has not been created by StartupAround.

Read Original Article

Popular Topics

Get the best stories from Startup Around on Telegram